Eric Gamazon Archive
-
January 13, 2020
Vanderbilt-led team discovers new genetic disease and defines underlying mechanism
An international research team has discovered a new genetic syndrome caused by mutation of a single gene and named it CATIFA, an acronym for its core symptoms. -
September 19, 2019
Gamazon receives NIH Genomic Innovator Award
VUMC's Eric Gamazon is one of only six investigators to receive an inaugural Genomic Innovator Award from the National Human Genome Research Institute, part of the NIH. -
April 24, 2019
Study merges big data and zebrafish biology to reveal mechanisms of human disease
In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease. -
October 11, 2018
Novel genetic study sheds new light on risk of heart attack
Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife. -
July 26, 2018
Vanderbilt study links gene expression, disease association data
An international team of researchers has integrated gene expression and disease association data to better understand the biological mechanisms of complex human diseases. -
February 15, 2018
Vanderbilt’s Gamazon named visiting fellow at Cambridge University
Eric Gamazon, PhD, research instructor in the Division of Genetic Medicine at Vanderbilt University School of Medicine, is spending part of the academic year at Cambridge University in England as one of 40 Clare Hall Visiting Fellows.